![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 47/64 | (2017.01) |
A61P 21/00 | (2006.01) | ||
A61K 31/712 | (2006.01) | ||
A61K 31/7125 | (2006.01) |
(11) | Number of the document | 3554553 |
(13) | Kind of document | T |
(96) | European patent application number | 17832401.8 |
Date of filing the European patent application | 2017-12-13 | |
(97) | Date of publication of the European application | 2019-10-23 |
(45) | Date of publication and mention of the grant of the patent | 2022-07-20 |
(46) | Date of publication of the claims translation | 2022-08-25 |
(86) | Number | PCT/US2017/066222 |
Date | 2017-12-13 |
(87) | Number | WO 2018/118599 |
Date | 2018-06-28 |
(30) | Number | Date | Country code |
201662436182 P | 2016-12-19 | US | |
201762443476 P | 2017-01-06 | US | |
201762479173 P | 2017-03-30 | US | |
201762562080 P | 2017-09-22 | US |
(72) |
PASSINI, Marco A. , US
HANSON, Gunnar J. , US
|
(73) |
Sarepta Therapeutics, Inc. ,
215 First Street, Suite 415, Cambridge, MA 02142,
US
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Egzoną šalinantys oligomero konjugatai nuo raumenų distrofojos |
EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY |
Payment date | Validity (years) | Amount | |
2024-11-22 | 8 | 185.00 EUR |
2025-12-13 |